ASP Isotopes announces CC of South Africa approved offer for Regeneron

ASP Isotopes (ASPI) announced that the Company’s proposed offer to acquire all of the issued ordinary shares of JSE-listed Renergen Limited has been approved as of July 23, 2025, by the Competition Commission of South Africa, CC of South Africa, subject to certain conditions, which are acceptable to the Company. The implementation of the Scheme remains subject to and will only become operative upon the fulfilment or, if applicable, waiver of the outstanding conditions, including various regulatory approvals and third party consents, by no later than September 30, 2025, unless extended. If all remaining conditions are fulfilled or, if applicable, waived, the Scheme is expected to become effective in the third quarter of 2025.